Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

GeneMedicine to begin phase I testing of IGF-I Gene Medicine

Jan. 9, 1997

Gene discovery collaboration announced

Jan. 9, 1997

ALRT announces new additions to the product pipeline

Jan. 9, 1997

Alendronate reduces occurrence of vertebral fractures in Fracture Intervention Trial

Jan. 9, 1997

Celtrix completes phase I studies of SomatoKine

Jan. 8, 1997

Leptin triggers reproductive function

Jan. 8, 1997

Bimoclomol progresses in trials

Jan. 8, 1997

Lilly synthesizes antiobesity proteins

Jan. 8, 1997

Kissei, Servier expand licensing agreement for antidiabetic drug

Jan. 7, 1997

Amgen, Progenitor sign agreement covering leptin receptor technology

Jan. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...